1
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
Condition(s):Multiple SclerosisLast Updated:July 21, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:July 21, 2009Completed
Condition(s):Relapsing-remitting Multiple SclerosisLast Updated:September 7, 2011Completed
Condition(s):Hereditary AngioedemaLast Updated:January 19, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.